ATE321871T1 - Ein autoreguliertes tetracyclin-reguliertes system fur die induzierte genexpression in eukaryoten - Google Patents

Ein autoreguliertes tetracyclin-reguliertes system fur die induzierte genexpression in eukaryoten

Info

Publication number
ATE321871T1
ATE321871T1 AT96921541T AT96921541T ATE321871T1 AT E321871 T1 ATE321871 T1 AT E321871T1 AT 96921541 T AT96921541 T AT 96921541T AT 96921541 T AT96921541 T AT 96921541T AT E321871 T1 ATE321871 T1 AT E321871T1
Authority
AT
Austria
Prior art keywords
tta
tetracycline
expression
ttak
autoregulatory
Prior art date
Application number
AT96921541T
Other languages
English (en)
Inventor
David G Schatz
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Application granted granted Critical
Publication of ATE321871T1 publication Critical patent/ATE321871T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/44Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96921541T 1995-06-07 1996-06-07 Ein autoreguliertes tetracyclin-reguliertes system fur die induzierte genexpression in eukaryoten ATE321871T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/474,169 US5851796A (en) 1995-06-07 1995-06-07 Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes

Publications (1)

Publication Number Publication Date
ATE321871T1 true ATE321871T1 (de) 2006-04-15

Family

ID=23882456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921541T ATE321871T1 (de) 1995-06-07 1996-06-07 Ein autoreguliertes tetracyclin-reguliertes system fur die induzierte genexpression in eukaryoten

Country Status (7)

Country Link
US (1) US5851796A (de)
EP (1) EP0832254B1 (de)
JP (1) JPH11507539A (de)
AT (1) ATE321871T1 (de)
AU (1) AU6274596A (de)
DE (1) DE69635992T2 (de)
WO (1) WO1996040946A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0870044T3 (da) * 1995-12-01 2004-08-02 Crucell Holland Bv Reguleret proteinekspression i stabilt transfekterede pattedyrsceller
US5891718A (en) * 1996-03-27 1999-04-06 Vical Incorporated Tetracycline inducible/repressible systems
DE19635568C1 (de) * 1996-09-02 1998-03-26 Gsf Forschungszentrum Umwelt Vektorsysteme zur konditionalen Genexpression
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression
US6087166A (en) * 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
US6878516B1 (en) 1998-01-16 2005-04-12 Pharmacia & Upjohn Company Autoregulatory system for validating microbial genes as possible antimicrobial targets using a tetracycline-controllable element
AU2312699A (en) * 1998-01-16 1999-08-02 Pharmacia & Upjohn Company An autoregulatory system for validating microbial genes as possible antimicrobial targets using tetracycline-controllable element
BR9908096A (pt) * 1998-02-19 2000-10-31 Eastern Virginia Med School Proteìna 3 da zona pelúcida humana (hzp3), ativa, recombinante
US7037663B2 (en) * 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
DE19831420A1 (de) * 1998-07-14 2000-01-20 Hoechst Marion Roussel De Gmbh Expressionssysteme enthaltend chimäre Promotoren mit Bindungsstellen für rekombinante Transkriptionsfaktoren
US20050037335A1 (en) * 1998-11-07 2005-02-17 Wolfgang Hillen Method for identifying novel transcriptional regulatory proteins
US6706491B1 (en) 1999-04-09 2004-03-16 The Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of genes regulated by p21
ATE458818T1 (de) * 1999-06-07 2010-03-15 Tet Systems Holding Gmbh & Co Tet repressor basierte transkriptionale regulatorische proteine
GB2355459B (en) 1999-11-29 2001-09-26 Isis Innovation A dominant conditional lethal genetic system
JP2005516586A (ja) * 2001-07-20 2005-06-09 ボード オブ トラスティーズ オブ ザ ユニヴァースティ オブ イリノイ 癌の処置に対する遺伝子標的を同定するための試薬および方法
EP1421104A4 (de) * 2001-08-02 2005-08-24 Trinity Biomedical Technology Humane zona-pellucida-proteine und verfahren zu deren verwendung bei der diagnose männlicher unfruchtbarkeit
GB2402675B (en) * 2003-05-12 2008-02-20 Oxitec Ltd Resistance dilution
GB2403475B (en) * 2003-07-01 2008-02-06 Oxitec Ltd Stable integrands
GB2404382B (en) 2003-07-28 2008-01-30 Oxitec Ltd Pest control
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
WO2005056752A2 (en) 2003-10-24 2005-06-23 Gencia Corporation Methods and compositions for delivering polynucleotides
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US20080307549A1 (en) 2005-08-03 2008-12-11 Adelaide Research & Innovation Pty Ltd. Polysaccharide Synthases
GB2443186A (en) 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
EP3159414A1 (de) * 2006-02-10 2017-04-26 Oxitec Limited Expressionssystem
US8080647B2 (en) * 2006-11-22 2011-12-20 Pioneer Hi Bred International Inc Tetracycline repressor and uses thereof
AU2007352618B2 (en) 2007-05-02 2013-07-18 Boehringer Ingelheim Animal Health USA Inc. DNA plasmids having improved expression and stability
EP2364322A1 (de) * 2008-10-28 2011-09-14 Pioneer Hi-Bred International Inc. Sulfonylharnstoffreaktive repressorproteine
US8124400B2 (en) 2008-12-10 2012-02-28 Synthetic Genomics, Inc. Production of branched-chain alcohols by photosynthetic microorganisms
WO2011008565A1 (en) 2009-06-29 2011-01-20 Synthetic Genomics, Inc. Acyl-acp thioesterase genes and uses therefor
WO2011019858A1 (en) 2009-08-11 2011-02-17 Synthetic Genomics, Inc. Microbial production of fatty alcohols
EP2719757A1 (de) 2009-09-04 2014-04-16 President and Fellows of Harvard College Herstellung sekretierter bioprodukte aus photosynthese-mikroben
EP2655615A4 (de) 2010-12-23 2014-04-23 Exxonmobil Res & Eng Co Prokaryotische acyl-acp-thioesterasen zur herstellung von fettsäuren in genetisch modifizierten mikroorganismen
AU2011349729B2 (en) 2010-12-23 2015-09-24 Exxonmobil Research And Engineering Company Genetically engineered microorganisms comprising 4-hydroxybenzoly-CoA thioesterases and methods of using the same for producing free fatty acids and fatty acid derivatives
US9187726B2 (en) 2010-12-23 2015-11-17 Exxonmobil Research And Engineering Company Culturing a microorganism in a medium with an elevated level of a carboxylate counterion source
EP2658963A4 (de) 2010-12-31 2014-05-14 Exxonmobil Res & Eng Co Verbesserung der biomasseproduktion durch disruption von lichtenergiedissipationswegen
WO2012135668A1 (en) 2011-03-31 2012-10-04 Exxonmobil Research And Engineering Company Metabolic pathway targeting by transcription factor overexpression
US20130005590A1 (en) 2011-06-06 2013-01-03 The Regents Of The University Of California Synthetic biology tools
MX2013015327A (es) 2011-06-30 2014-01-31 Exxonmobil Res & Eng Co Regulacion de genes toxina y antitoxina para contencion biologica.
CN103975070A (zh) 2011-09-27 2014-08-06 艾克森美孚研究与工程公司 酰基-酰基载体蛋白(acyl-acp)蜡酯合酶
US9096834B2 (en) 2012-02-24 2015-08-04 Exxonmobil Research And Engineering Company Recombinant microorganisms comprising thioesterase and lysophosphatidic acid acyltransferase genes for fatty acid production
PT2814972T (pt) 2012-02-24 2020-06-16 Exxonmobil Res & Eng Co Produção melhorada de ácidos gordos e derivados de ácidos gordos por micro-organismos recombinantes
US8962299B2 (en) 2012-02-29 2015-02-24 Exxonmobil Research And Engineering Company Four-gene pathway for wax ester synthesis
GB2500113A (en) 2012-03-05 2013-09-11 Oxitec Ltd Arthropod male germline gene expression system
US9181568B2 (en) 2012-04-23 2015-11-10 Exxonmobil Research And Engineering Company Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases
GB201303932D0 (en) 2013-03-05 2013-04-17 Oxitec Ltd Muscle actin promoter
GB2526867A (en) 2014-06-05 2015-12-09 Oxitec Ltd Gene expression system
AU2016318230B2 (en) 2015-09-11 2020-05-21 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
US20170267984A1 (en) 2016-03-18 2017-09-21 Exxonmobil Research And Engineering Company Chlorophyllase overproduction to enhance photosynthetic efficiency
WO2018007526A1 (en) * 2016-07-06 2018-01-11 Danmarks Tekniske Universitet Use of prokaryotic transcriptional activators as metabolite biosensors in eukaryotic cells
US11866733B2 (en) 2016-08-01 2024-01-09 University of Pittsburgh—of the Commonwealth System of Higher Education Human induced pluripotent stem cells for high efficiency genetic engineering
US11827876B2 (en) 2016-08-12 2023-11-28 Oxitec Ltd. Self-limiting, sex-specific gene and methods of using
TW201907937A (zh) 2017-05-08 2019-03-01 美商葛利史東腫瘤科技公司 阿爾法病毒新抗原載體
WO2019169291A1 (en) 2018-03-02 2019-09-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of il-34 to treat retinal inflammation and neurodegeneration
AR117409A1 (es) 2018-03-29 2021-08-04 Oxitec Ltd Noctuidas autolimitantes
CN112166193A (zh) 2018-05-21 2021-01-01 生物权威(英国)有限公司 具有经修饰的接头结构域的嵌合抗原受体及其用途
MX2021014525A (es) 2019-05-30 2022-03-17 Gritstone Bio Inc Adenovirus modificados.
US12534512B2 (en) 2019-11-11 2026-01-27 Vanderbilt University Human monoclonal antibodies to hantavirus and methods of use therefore
EP4192496A4 (de) 2020-08-06 2025-01-01 Gritstone bio, Inc. Multiepitop-impfstoffkassetten
AU2021337747A1 (en) * 2020-09-05 2023-02-23 Ginkgo Bioworks, Inc. Synthetic expression systems
WO2022241455A1 (en) * 2021-05-12 2022-11-17 Baylor College Of Medicine A synthetic circuit for buffering gene dosage variation between individual mammalian cells
US20240384277A1 (en) * 2021-06-15 2024-11-21 Modernatx, Inc. Engineered polynucleotides for cell-type or microenvironment-specific expression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3934454A1 (de) * 1989-10-14 1991-04-18 Merck Patent Gmbh Regulierbare expressionsvektoren fuer bacillus
WO1991019784A1 (en) * 1990-06-13 1991-12-26 The Trustees Of Princeton University A Lac REPRESSOR-HSV VP16 CHIMERIC TRANSCRIPTIONAL ACTIVATOR PROTEIN SYSTEM FUNCTIONING IN TRANSFECTED MAMMALIAN CELLS
GB9028062D0 (en) * 1990-12-24 1991-02-13 Agricultural & Food Res Production of transgenic animals
DE4100594A1 (de) * 1991-01-08 1992-07-09 Inst Genbiologische Forschung Neue plasmide zur zeitlichen und oertlichen kontrollierten expression eines heterologen produktes in pflanzen
AU664847B2 (en) * 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
GB9113097D0 (en) * 1991-06-18 1991-08-07 Boehringer Ingelheim Int Chimeric gene
US5464758A (en) * 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5866755A (en) * 1993-06-14 1999-02-02 Basf Aktiengellschaft Animals transgenic for a tetracycline-regulated transcriptional inhibitor

Also Published As

Publication number Publication date
DE69635992T2 (de) 2007-02-01
WO1996040946A1 (en) 1996-12-19
EP0832254A1 (de) 1998-04-01
EP0832254B1 (de) 2006-03-29
US5851796A (en) 1998-12-22
AU6274596A (en) 1996-12-30
JPH11507539A (ja) 1999-07-06
DE69635992D1 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
DE69635992D1 (de) Ein autoreguliertes tetracyclin-reguliertes system fur die induzierte genexpression in eukaryoten
Müller et al. Multi-chromatic control of mammalian gene expression and signaling
Schäfer et al. Translational control in spermatogenesis
Lee et al. Deep functional redundancy between FAMA and FOUR LIPS in stomatal development
WO2000032748A1 (en) Gene networks for control of gene expression
ATE505556T1 (de) Mehrfach-induzierbares genregulierungssystem
DK0804565T3 (da) Tetracyklin-regulerede transkriptionsmodulatorer
ATE526406T1 (de) Kontrolle der genexpression
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
DE60022369D1 (de) Verfahren zur regulation der transkription von fremden genen in gegenwart von stickstoff
ATE443437T1 (de) Modifiziertes bacillus thuringiensis gen zur kontrolle von lepidoptera in pflanzen
Heger et al. New tools in the box: an evolutionary synopsis of chromatin insulators
Nikolic Autoregulation of bacterial gene expression: lessons from the MazEF toxin–antitoxin system
Huynh et al. A Drosophila CRISPR/Cas9 toolkit for conditionally manipulating gene expression in the prothoracic gland as a test case for polytene tissues
AR025485A1 (es) Secuencias regulatorias para el control selectivo de la expresion de genes en plantas
NO983775L (no) Regulering av gen-ekspresjon i eukaryoter
Schönig et al. The power of reversibility: regulating gene activities via tetracycline-controlled transcription
Barr et al. Synthetic enhancer design by in silico compensatory evolution reveals flexibility and constraint in cis-regulation
AR025684A1 (es) Secuencias regulatorias para el control de la expresion de genes en plantas
ATE443762T1 (de) Induktierbare transposition beim transgenen organismus mit transposon-vektor
Nguyen et al. Role of riboswitches in gene regulation and their potential for algal biotechnology
ATE296886T1 (de) Männliche fertilität vermittelnde nukleotidsequenzen und verfahren zu ihrer verwendung
ATE135120T1 (de) Verfahren zum ansteuern von elektrischen, stromgesteuerten stellgliedern
Scherrer Control of gene expression in animal cells: the cascade regulation hypothesis revisited
Sullenger Revising messages traveling along the cellular information superhighway

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0832254

Country of ref document: EP